Evidence map›Paper›PMID 39394199›Full record

ArticleNature communications2024

LRRTM2 controls presynapse nano-organization and AMPA receptor sub-positioning through Neurexin-binding interface.

Konstantina Liouta, Malgorzata Lubas, Vasika Venugopal, Julia Chabbert, Caroline Jeannière, Candice Diaz, Matthieu Munier, Béatrice Tessier, Stéphane Claverol, Alexandre Favereaux and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. bioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Konstantina LioutaInterdisciplinary Institute for Neuroscience, Centre National de la Recherche Scientifique, Bordeaux, France.ORCID 0000-0001-6232-5458
Malgorzata Lubas *Interdisciplinary Institute for Neuroscience, Centre National de la Recherche Scientifique, Bordeaux, France.
Vasika Venugopal *Interdisciplinary Institute for Neuroscience, Centre National de la Recherche Scientifique, Bordeaux, France.ORCID 0000-0002-9423-1517
Julia ChabbertInterdisciplinary Institute for Neuroscience, Centre National de la Recherche Scientifique, Bordeaux, France.
Caroline JeannièreInterdisciplinary Institute for Neuroscience, Centre National de la Recherche Scientifique, Bordeaux, France.
Candice DiazInterdisciplinary Institute for Neuroscience, Centre National de la Recherche Scientifique, Bordeaux, France.
Matthieu MunierInterdisciplinary Institute for Neuroscience, Centre National de la Recherche Scientifique, Bordeaux, France.
Béatrice TessierInterdisciplinary Institute for Neuroscience, Centre National de la Recherche Scientifique, Bordeaux, France.ORCID 0000-0001-9398-6101
Stéphane ClaverolUniversity of Bordeaux, Bordeaux Proteome, Bordeaux, France.ORCID 0000-0001-5315-2823
Alexandre FavereauxInterdisciplinary Institute for Neuroscience, Centre National de la Recherche Scientifique, Bordeaux, France.
Matthieu SainlosInterdisciplinary Institute for Neuroscience, Centre National de la Recherche Scientifique, Bordeaux, France.
Joris de WitVIB Center for Brain & Disease Research, Leuven, Belgium.ORCID 0000-0003-1120-1089
Mathieu LetellierInterdisciplinary Institute for Neuroscience, Centre National de la Recherche Scientifique, Bordeaux, France.ORCID 0000-0003-4008-298X
Olivier ThoumineInterdisciplinary Institute for Neuroscience, Centre National de la Recherche Scientifique, Bordeaux, France.ORCID 0000-0002-8041-1349
Ingrid ChammaInterdisciplinary Institute for Neuroscience, Centre National de la Recherche Scientifique, Bordeaux, France. ingrid.chamma@u-bordeaux.fr.ORCID 0000-0002-4402-3859

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-17-CE16-0028-01Agence Nationale de la Recherche (French National Research Agency) nanoPROBE, ANR-19-CE11-0025Fondation pour la Recherche Médicale (Foundation for Medical Research in France) DEQ20160334916
6 · The paper itself

Abstract

Synapses are organized into nanocolumns that control synaptic transmission efficacy through precise alignment of postsynaptic neurotransmitter receptors and presynaptic release sites. Recent evidence show that Leucine-Rich Repeat Transmembrane protein LRRTM2, highly enriched and confined at synapses, interacts with Neurexins through its C-terminal cap, but the role of this binding interface has not been explored in synapse formation and function. Here, we develop a conditional knock-out mouse model (cKO) to address the molecular mechanisms of LRRTM2 regulation, and its role in synapse organization and function. We show that LRRTM2 cKO specifically impairs excitatory synapse formation and function in mice. Surface expression, synaptic clustering, and membrane dynamics of LRRTM2 are tightly controlled by selective motifs in the C-terminal domain. Conversely, the N-terminal domain controls presynapse nano-organization and postsynapse AMPAR sub-positioning and stabilization through the recently identified Neurexin-binding interface. Thus, we identify LRRTM2 as a central organizer of pre- and post- excitatory synapse nanostructure through interaction with presynaptic Neurexins.

Indexed as

Membrane ProteinsMice, KnockoutNerve Tissue ProteinsReceptors, AMPASynapsesAnimalsHippocampusMaleMiceProtein BindingSynaptic TransmissionLRRTM2 protein, mouseMembrane ProteinsNerve Tissue ProteinsReceptors, AMPA

Identifiers

PMID39394199
PMCPMC11470055

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.